Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Fätkenheuer G[au]:

Search results

Items: 1 to 50 of 334

1.

The Diagnosis and Treatment of Tuberculosis.

Suárez I, Fünger SM, Kröger S, Rademacher J, Fätkenheuer G, Rybniker J.

Dtsch Arztebl Int. 2019 Oct 25;116(43):729-735. doi: 10.3238/arztebl.2019.0729.

2.

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.

Vieillard V, Combadière B, Tubiana R, Launay O, Pialoux G, Cotte L, Girard PM, Simon A, Dudoit Y, Reynes J, Rockstroh J, Garcia F, Gatell J, Devidas A, Yazdanpanah Y, Weiss L, Fätkenheuer G, Autran B, Joyeux D, Gharakhanian S, Debré P, Katlama C.

NPJ Vaccines. 2019 Jun 3;4:25. doi: 10.1038/s41541-019-0117-5. eCollection 2019. Erratum in: NPJ Vaccines. 2019 Aug 13;4:36.

3.

Severe disseminated tuberculosis in HIV-negative refugees.

Suárez I, Maria Fünger S, Jung N, Lehmann C, Reimer RP, Mehrkens D, Bunte A, Plum G, Jaspers N, Schmidt M, Fätkenheuer G, Rybniker J.

Lancet Infect Dis. 2019 Oct;19(10):e352-e359. doi: 10.1016/S1473-3099(19)30162-8. Epub 2019 Jun 7. Review.

PMID:
31182290
4.

Systematic Review And Meta-Analysis of Treatment Interruptions in HIV-1 Infected Patients Receiving Antiretroviral Therapy: Implications for Future HIV Cure Trials.

Stecher M, Claßen A, Klein F, Lehmann C, Gruell H, Platten M, Wyen C, Behrens G, Fätkenheuer G, Vehreschild JJ.

Clin Infect Dis. 2019 May 18. pii: ciz417. doi: 10.1093/cid/ciz417. [Epub ahead of print]

PMID:
31102444
5.

Diagnostic challenges in infective endocarditis: is PET/CT the solution?

Hohmann C, Michels G, Schmidt M, Pfister R, Mader N, Ohler M, Blanke L, Jazmati N, Lehmann C, Rybniker J, Fünger SM, Fätkenheuer G, Jung N.

Infection. 2019 Aug;47(4):579-587. doi: 10.1007/s15010-019-01278-6. Epub 2019 Feb 13.

PMID:
30847769
6.

Correction to: Antiretroviral treatment indications and adherence to the German-Austrian treatment initiation guidelines in the German ClinSurv HIV Cohort between 1999 and 2016.

Stecher M, Schommers P, Schmidt D, Kollan C, Gunsenheimer-Bartmeyer B, Lehmann C, Platten M, Fätkenheuer G, Vehreschild JJ; ClinSurv Study Group.

Infection. 2019 Apr;47(2):257. doi: 10.1007/s15010-019-01281-x.

PMID:
30805900
7.

[Modern HIV treatment].

Lehmann C, Malin J, Suárez I, Fätkenheuer G.

Internist (Berl). 2019 Apr;60(4):411-419. doi: 10.1007/s00108-019-0564-0. Review. German.

PMID:
30778612
8.

Combination Antimicrobial Therapy for Enterococcus faecalis Infective Endocarditis.

Koehler P, Jung N, Cornely OA, Rybniker J, Fätkenheuer G.

Clin Infect Dis. 2019 Aug 16;69(5):900. doi: 10.1093/cid/ciz054. No abstract available.

PMID:
30715308
9.

HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?

Drößler L, Lehmann C, Töpelt K, Nierhoff D, Vehreschild JJ, Rybniker J, Hallek M, Fischer J, Stormberg V, Fätkenheuer G, Wieland U, Jung N.

Infection. 2019 Apr;47(2):293-300. doi: 10.1007/s15010-019-01271-z. Epub 2019 Jan 28.

PMID:
30689161
10.

Pelvic cellulitis caused by Raoultella planticola in a neutropenic patient.

Al-Sawaf O, Garcia-Borrega J, Vehreschild JJ, Thelen P, Fätkenheuer G, Shimabukuro-Vornhagen A, Kochanek M, Böll B.

J Infect Chemother. 2019 Apr;25(4):298-301. doi: 10.1016/j.jiac.2018.09.013. Epub 2018 Oct 25.

PMID:
30482700
11.

Antiretroviral treatment indications and adherence to the German-Austrian treatment initiation guidelines in the German ClinSurv HIV Cohort between 1999 and 2016.

Stecher M, Schommers P, Schmidt D, Kollan C, Gunsenheimer-Bartmeyer B, Lehmann C, Platten M, Fätkenheuer G, Vehreschild JJ; ClinSurv Study Group.

Infection. 2019 Apr;47(2):247-255. doi: 10.1007/s15010-018-1248-8. Epub 2018 Nov 9. Erratum in: Infection. 2019 Feb 25;:.

PMID:
30414065
12.

Pretreatment human immunodeficiency virus type 1 (HIV-1) drug resistance in transmission clusters of the Cologne-Bonn region, Germany.

Stecher M, Chaillon A, Eis-Hübinger AM, Lehmann C, Fätkenheuer G, Wasmuth JC, Knops E, Vehreschild JJ, Mehta S, Hoenigl M.

Clin Microbiol Infect. 2019 Feb;25(2):253.e1-253.e4. doi: 10.1016/j.cmi.2018.09.025. Epub 2018 Oct 10.

PMID:
30315957
13.

Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations.

Laut KG, Shepherd L, Gottfredsson M, Sedlacek D, Knysz B, Begovac J, Radoi R, Schmied B, Chkhartishvili N, Florence E, Ristola M, Fätkenheuer G, Mulcahy F, Schmid P, Kuzovatova E, Paduta D, Smidt J, Domingo P, Szlávik J, Lundgren J, Mocroft A, Kirk O; EuroSIDA study group.

AIDS. 2018 Nov 28;32(18):2807-2819. doi: 10.1097/QAD.0000000000002035.

PMID:
30289816
14.

Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals.

Bar-On Y, Gruell H, Schoofs T, Pai JA, Nogueira L, Butler AL, Millard K, Lehmann C, Suárez I, Oliveira TY, Karagounis T, Cohen YZ, Wyen C, Scholten S, Handl L, Belblidia S, Dizon JP, Vehreschild JJ, Witmer-Pack M, Shimeliovich I, Jain K, Fiddike K, Seaton KE, Yates NL, Horowitz J, Gulick RM, Pfeifer N, Tomaras GD, Seaman MS, Fätkenheuer G, Caskey M, Klein F, Nussenzweig MC.

Nat Med. 2018 Nov;24(11):1701-1707. doi: 10.1038/s41591-018-0186-4. Epub 2018 Sep 26.

15.

Combination therapy with anti-HIV-1 antibodies maintains viral suppression.

Mendoza P, Gruell H, Nogueira L, Pai JA, Butler AL, Millard K, Lehmann C, Suárez I, Oliveira TY, Lorenzi JCC, Cohen YZ, Wyen C, Kümmerle T, Karagounis T, Lu CL, Handl L, Unson-O'Brien C, Patel R, Ruping C, Schlotz M, Witmer-Pack M, Shimeliovich I, Kremer G, Thomas E, Seaton KE, Horowitz J, West AP Jr, Bjorkman PJ, Tomaras GD, Gulick RM, Pfeifer N, Fätkenheuer G, Seaman MS, Klein F, Caskey M, Nussenzweig MC.

Nature. 2018 Sep;561(7724):479-484. doi: 10.1038/s41586-018-0531-2. Epub 2018 Sep 26.

16.

[The 2017/2018 influenza season-business as usual? : A statement of medical societies].

Kochanek M, Böll B, Shimabukuro-Vornhagen A, Welte T, Wieland U, Pletz M, Hallek M, Fätkenheuer G, Salzberger B.

Internist (Berl). 2018 Oct;59(10):1122-1124. doi: 10.1007/s00108-018-0501-7. German. No abstract available.

PMID:
30218201
17.

Vancomycin-resistant enterococci (VRE): a reason to isolate?

Vehreschild MJGT, Haverkamp M, Biehl LM, Lemmen S, Fätkenheuer G.

Infection. 2019 Feb;47(1):7-11. doi: 10.1007/s15010-018-1202-9. Epub 2018 Sep 3. Review.

PMID:
30178076
18.

Hotspots of Transmission Driving the Local Human Immunodeficiency Virus Epidemic in the Cologne-Bonn Region, Germany.

Stecher M, Hoenigl M, Eis-Hübinger AM, Lehmann C, Fätkenheuer G, Wasmuth JC, Knops E, Vehreschild JJ, Mehta S, Chaillon A.

Clin Infect Dis. 2019 Apr 24;68(9):1539-1546. doi: 10.1093/cid/ciy744.

19.

Infectious disease services: a survey from four university hospitals in Germany.

Rieg S, Hitzenbichler F, Hagel S, Suarez I, Kron F, Salzberger B, Pletz M, Kern WV, Fätkenheuer G, Jung N.

Infection. 2019 Feb;47(1):27-33. doi: 10.1007/s15010-018-1191-8. Epub 2018 Aug 17.

PMID:
30120718
20.

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.

Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ Jr, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA.

JAMA. 2018 Jul 24;320(4):379-396. doi: 10.1001/jama.2018.8431.

21.

To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.

Scholten M, Suárez I, Platten M, Kümmerle T, Jung N, Wyen C, Ernst A, Horn C, Burst V, Suárez V, Rybniker J, Fätkenheuer G, Lehmann C.

HIV Med. 2018 Oct;19(9):645-653. doi: 10.1111/hiv.12645. Epub 2018 Jul 11.

PMID:
29993176
22.

Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions - Cologne/Bonn, Munich and Hannover, 1999-2016.

Stecher M, Chaillon A, Eberle J, Behrens GMN, Eis-Hübinger AM, Lehmann C, Jablonka A, Bogner J, Fätkenheuer G, Spinner CD, Wasmuth JC, Kaiser R, Mehta SR, Vehreschild JJ, Hoenigl M.

Sci Rep. 2018 May 1;8(1):6799. doi: 10.1038/s41598-018-25004-8.

23.

Prevalence of Anti-HBs Without Anti-HBc Among HIV-Infected Adults Initiating Antiretroviral Therapy in Lilongwe, Malawi.

Demir M, Phiri S, Heger E, Heller T, Kaiser R, Chaweza T, Fätkenheuer G, Steffen HM, Neuhann F.

J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):e14-e15. doi: 10.1097/QAI.0000000000001681. No abstract available.

PMID:
29543637
24.

[Infectious diseases - a specialty of internal medicine].

Fätkenheuer G, Jung N, Kern WV, Fölsch UR, Salzberger B.

Internist (Berl). 2018 Apr;59(4):334-340. doi: 10.1007/s00108-018-0387-4. Review. German.

PMID:
29459991
25.

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.

Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, Fätkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JA, Sterling TR; Antiretroviral Therapy Cohort Collaboration (ART-CC) investigators.

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25031.

26.

Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort.

Roen A, Laut K, Pelchen-Matthews A, Borodulina E, Caldeira L, Clarke A, Clotet B, d'Arminio Monforte A, Fätkenheuer G, Gatell Artigas JM, Karpov I, Kuznetsova A, Kyselyova G, Mozer-Lisewska I, Mulcahy F, Ragone L, Scherrer A, Uzdaviniene V, Vandekerckhove L, Vannappagari V, Ostergaard L, Mocroft A; EuroSIDA study.

HIV Med. 2018 Apr;19(4):252-260. doi: 10.1111/hiv.12573. Epub 2017 Dec 22.

PMID:
29271606
27.

Case Report: A Cryptosporidium infection in a patient with relapsed T-lymphoblastic lymphoma undergoing allogeneic stem cell transplantation.

Schiller J, Klein S, Engels M, Büttner R, Rybniker J, Fätkenheuer G, Scheid C, Wybranski C, Quaas A, Reinhardt HC, Flümann R.

Eur J Haematol. 2018 Apr;100(4):383-385. doi: 10.1111/ejh.12998. Epub 2017 Dec 17.

PMID:
29140544
28.

Treatment of Early Syphilis.

Fätkenheuer G, Suarez I, Platten M, Fabri M, Lehmann C.

Clin Infect Dis. 2017 Oct 30;65(10):1767. doi: 10.1093/cid/cix591. No abstract available.

PMID:
29091229
29.

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.

Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Fätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valadas E, Colin C, Friis-Møller N, Costagliola D, Thiebaut R, Chene G, Matheron S; COHERE in EuroCoord and ACHIeV2e Study Group.

J Antimicrob Chemother. 2017 Oct 1;72(10):2869-2878. doi: 10.1093/jac/dkx210.

30.

European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary.

De Wit S, Battegay M, D'Arminio Monforte A, Lundgren JD, Oprea C, Antinori A, Bhagani S, Fätkenheuer G, Friis-Moller N, Furrer H, Mussini C; European AIDS Clinical Society.

HIV Med. 2018 Feb;19(2):77-80. doi: 10.1111/hiv.12559. Epub 2017 Oct 27.

PMID:
29076235
31.

Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016.

Lehmann C, Kochanek M, Abdulla D, Becker S, Böll B, Bunte A, Cadar D, Dormann A, Eickmann M, Emmerich P, Feldt T, Frank C, Fries J, Gabriel M, Goetsch U, Gottschalk R, Günther S, Hallek M, Häussinger D, Herzog C, Jensen B, Kolibay F, Krakau M, Langebartels G, Rieger T, Schaade L, Schmidt-Chanasit J, Schömig E, Schüttfort G, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M, Wieland U, Wiesmüller G, Wolf T, Fätkenheuer G.

Euro Surveill. 2017 Sep;22(39). doi: 10.2807/1560-7917.ES.2017.22.39.17-00088.

32.

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.

Cozzi-Lepri A, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, Schmid P, Gottfredsson M, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso MH, Lundgren JD, Mocroft A; EuroSIDA Study Group.

HIV Med. 2018 Feb;19(2):102-117. doi: 10.1111/hiv.12557. Epub 2017 Oct 6.

33.

Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae.

Salzberger B, Fätkenheuer G.

Lancet Infect Dis. 2017 Oct;17(10):1020. doi: 10.1016/S1473-3099(17)30521-2. No abstract available.

PMID:
28948922
34.

On Taking a Different Route: An Unlikely Case of Malaria by Nosocomial Transmission.

Gruell H, Hamacher L, Jennissen V, Tuchscherer A, Ostendorf N, Löffler T, Hallek M, Kochanek M, Tannich E, Böll B, Fätkenheuer G.

Clin Infect Dis. 2017 Oct 15;65(8):1404-1406. doi: 10.1093/cid/cix520.

PMID:
28575383
35.

Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.

Suárez I, Lehmann C, Gruell H, Graeb J, Kochanek M, Fätkenheuer G, Plum G, van Wengen A, van de Vosse E, Hartmann P, Hanitsch LG, Rybniker J.

Clin Infect Dis. 2017 Aug 1;65(3):518-521. doi: 10.1093/cid/cix372.

PMID:
28430999
36.

Screening and contact precautions - A survey on infection control measures for multidrug-resistant bacteria in German university hospitals.

Biehl LM, Bertz H, Bogner J, Dobermann UH, Kessel J, Krämer C, Lemmen S, von Lilienfeld-Toal M, Peter S, Pletz MW, Rohde H, Schmiedel S, Schubert S, Ullmann AJ, Fätkenheuer G, Vehreschild MJGT.

Antimicrob Resist Infect Control. 2017 Apr 13;6:37. doi: 10.1186/s13756-017-0191-2. eCollection 2017.

37.

[Strategies for the Treatment of Community-Acquired Pneumonia in HIV-Positive Patients].

Schleenvoigt BT, Rupp J, Rohde G, Rockstroh JK, Fätkenheuer G, Pletz MW.

Pneumologie. 2017 Apr;71(4):207-214. doi: 10.1055/s-0043-101254. Epub 2017 Apr 13. German.

PMID:
28407674
38.

Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.

Suárez I, Roderus L, van Gumpel E, Jung N, Lehmann C, Fätkenheuer G, Hartmann P, Plum G, Rybniker J.

Infection. 2017 Jun;45(3):341-347. doi: 10.1007/s15010-017-1005-4. Epub 2017 Mar 16.

PMID:
28303545
39.

The "Choosing Wisely" initiative in infectious diseases.

Lehmann C, Berner R, Bogner JR, Cornely OA, de With K, Herold S, Kern WV, Lemmen S, Pletz MW, Ruf B, Salzberger B, Stellbrink HJ, Suttorp N, Ullmann AJ, Fätkenheuer G, Jung N.

Infection. 2017 Jun;45(3):263-268. doi: 10.1007/s15010-017-0997-0. Epub 2017 Mar 13. Review.

PMID:
28290130
40.

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals.

Caskey M, Schoofs T, Gruell H, Settler A, Karagounis T, Kreider EF, Murrell B, Pfeifer N, Nogueira L, Oliveira TY, Learn GH, Cohen YZ, Lehmann C, Gillor D, Shimeliovich I, Unson-O'Brien C, Weiland D, Robles A, Kümmerle T, Wyen C, Levin R, Witmer-Pack M, Eren K, Ignacio C, Kiss S, West AP Jr, Mouquet H, Zingman BS, Gulick RM, Keler T, Bjorkman PJ, Seaman MS, Hahn BH, Fätkenheuer G, Schlesinger SJ, Nussenzweig MC, Klein F.

Nat Med. 2017 Feb;23(2):185-191. doi: 10.1038/nm.4268. Epub 2017 Jan 16.

41.

Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.

Schwameis M, Kündig T, Huber G, von Bidder L, Meinel L, Weisser R, Aberer E, Härter G, Weinke T, Jelinek T, Fätkenheuer G, Wollina U, Burchard GD, Aschoff R, Nischik R, Sattler G, Popp G, Lotte W, Wiechert D, Eder G, Maus O, Staubach-Renz P, Gräfe A, Geigenberger V, Naudts I, Sebastian M, Reider N, Weber R, Heckmann M, Reisinger EC, Klein G, Wantzen J, Jilma B.

Lancet Infect Dis. 2017 Mar;17(3):322-329. doi: 10.1016/S1473-3099(16)30529-1. Epub 2016 Dec 20. Erratum in: Lancet Infect Dis. 2017 Nov 21;:.

PMID:
28007428
42.

Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial.

Rockstroh JK, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Zhang-Roper R, Wang R, Pineda JA, Heera J.

Antivir Ther. 2017;22(3):263-269. doi: 10.3851/IMP3116. Epub 2016 Dec 7.

PMID:
27924779
43.

Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany.

Schwarze-Zander C, Draenert R, Lehmann C, Stecher M, Boesecke C, Sammet S, Wasmuth JC, Seybold U, Gillor D, Wieland U, Kümmerle T, Strassburg CP, Mankertz A, Eis-Hübinger AM, Jäger G, Fätkenheuer G, Bogner JR, Rockstroh JK, Vehreschild JJ.

Epidemiol Infect. 2017 Jan;145(2):236-244. Epub 2016 Oct 26.

PMID:
27780480
44.

HIV/Hepatitis C Virus Co-infection among Adults Beginning Antiretroviral Therapy, Malawi.

Demir M, Phiri S, Kaiser R, Chaweza T, Neuhann F, Tweya H, Fätkenheuer G, Steffen HM.

Emerg Infect Dis. 2016 Nov;22(11):2018-2020. doi: 10.3201/eid2211.160892. No abstract available.

45.

Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.

Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A; Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

HIV Med. 2017 Mar;18(3):171-180. doi: 10.1111/hiv.12411. Epub 2016 Sep 14.

46.

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.

Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R; Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

HIV Med. 2017 Jan;18(1):33-44. doi: 10.1111/hiv.12389. Epub 2016 Sep 14.

47.

Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site.

Gristick HB, von Boehmer L, West AP Jr, Schamber M, Gazumyan A, Golijanin J, Seaman MS, Fätkenheuer G, Klein F, Nussenzweig MC, Bjorkman PJ.

Nat Struct Mol Biol. 2016 Oct;23(10):906-915. doi: 10.1038/nsmb.3291. Epub 2016 Sep 12.

48.

Draft Genome Sequences of Nine Clinical Isolates of Vancomycin-Resistant Enterococci.

Higgins PG, Koehler D, Chan JZ, Cornely OA, Fätkenheuer G, Gillis M, Pallen MJ, Tien J, Seifert H, Vehreschild MJ, Millard AD.

Genome Announc. 2016 Aug 18;4(4). pii: e00803-16. doi: 10.1128/genomeA.00803-16.

49.

Antigen-presenting human B cells are expanded in inflammatory conditions.

Shimabukuro-Vornhagen A, García-Márquez M, Fischer RN, Iltgen-Breburda J, Fiedler A, Wennhold K, Rappl G, Abken H, Lehmann C, Herling M, Wolf D, Fätkenheuer G, Rubbert-Roth A, Hallek M, Theurich S, von Bergwelt-Baildon M.

J Leukoc Biol. 2017 Feb;101(2):577-587. doi: 10.1189/jlb.5A0416-182R. Epub 2016 Aug 17.

PMID:
27534894
50.

Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey.

Lazarus JV, Laut KG, Safreed-Harmon K, Peters L, Johnson M, Fätkenheuer G, Khromova I, Vandekerckhove L, Maciejewska K, Radoi R, Ridolfo AL, Mocroft A.

BMC Infect Dis. 2016 Jul 20;16:335. doi: 10.1186/s12879-016-1685-x.

Supplemental Content

Loading ...
Support Center